Macquarie Group’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-7,801	Closed	-$902K	–	1713
2023 Q3	$902K	Buy	7,801 +1,744	+29%	+$187K	﹤0.01%	1363
2023 Q2	$623K	Sell	6,057 -2,772	-31%	-$292K	﹤0.01%	1432
2023 Q1	$964K	Sell	8,829 -79,685	-90%	-$8.81M	﹤0.01%	1366
2022 Q4	$10.1M	Sell	88,514 -1,719,050	-95%	-$143M	0.01%	834
2022 Q3	$112M	Sell	1,807,564 -45,054	-2%	-$3.15M	0.14%	191
2022 Q2	$148M	Sell	1,852,618 -84,649	-4%	-$8.02M	0.17%	144
2022 Q1	$204K	Buy	1,937,267 +178,354	+10%	+$17.4M	0.16%	128
2021 Q4	$190M	Buy	1,758,913 +132,842	+8%	+$14.5M	0.16%	162
2021 Q3	$178M	Buy	1,626,071 +55,058	+4%	+$5.72M	0.15%	161
2021 Q2	$147M	Buy	1,571,013 +1,561,546	+16,495%	+$144M	0.12%	205
2021 Q1	$872K	Hold	9,467	–	–	﹤0.01%	1426
2020 Q4	$693K	Buy	9,467 +1,210	+15%	+$89.9K	﹤0.01%	1393
2020 Q3	$641K	Hold	8,257	–	–	﹤0.01%	1346
2020 Q2	$459K	Sell	8,257 -1,043	-11%	-$44.6K	﹤0.01%	1367
2020 Q1	$275K	Hold	9,300	–	–	﹤0.01%	1386
2019 Q4	$337K	Buy	+9,300	New	+$285K	﹤0.01%	1481
2019 Q2	–	Sell	-96,636	Closed	-$2.55M	–	1910
2019 Q1	$2.55M	Buy	96,636 +96,536	+96,536%	+$2.29M	﹤0.01%	927
2018 Q4	$2K	Sell	100 -1,600	-94%	-$31.4K	﹤0.01%	2222
2018 Q3	$33K	Sell	1,700 -17,300	-91%	-$329K	﹤0.01%	1802
2018 Q2	$315K	Sell	19,000 -10,200	-35%	-$156K	﹤0.01%	1510
2018 Q1	$415K	Buy	29,200 +16,300	+126%	+$241K	﹤0.01%	1451
2017 Q4	$188K	Buy	12,900 +8,700	+207%	+$122K	﹤0.01%	1747
2017 Q3	$53K	Buy	+4,200	New	+$53.4K	﹤0.01%	2000

Other funds holding HZNP